20 (AIDX) Change in Receivables (2025 - 2026)
20's (AIDX) quarterly Change in Receivables came in at $1527.0 in Q1 2026, up 127.22% YoY from $672.04 in Q1 2025, and up 127.22% on a QoQ basis from -$5610.0 in Q1 2025.
20 (AIDX) Change in Receivables (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Change in Receivables data on file, last reported at $1527.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | -90.00 Mn |
| 10 | 20 | 5.55 Mn | 1.00 Mn | 304,727.00 | 90,005.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,527.00 |
| Mar 31, 2026 | 1,527.00 |
| Mar 31, 2025 | -5,610.00 |
| Mar 31, 2025 | -5,610.00 |